In contrast, a number of studies have demonstrated that tumour growth can be altered by inhibition of NOS, both in vitro and in vivo, although most of these studies sought to modulate iNOS rather than eNOS activity [46, 47]. The gene discussed is NOS2; the disease is neoplasm.